name: Atrial Fibrillation
creation_date: '2025-12-18T17:01:35Z'
updated_date: '2026-02-27T12:00:00Z'
category: Complex
parents:
- Cardiovascular Disease
- Cardiac Arrhythmia
disease_term:
  preferred_term: atrial fibrillation
  term:
    id: MONDO:0004981
    label: atrial fibrillation
has_subtypes:
- name: Paroxysmal Atrial Fibrillation
  description: Episodes terminate spontaneously within 7 days.
- name: Persistent Atrial Fibrillation
  description: Episodes last longer than 7 days or require intervention.
- name: Long-standing Persistent Atrial Fibrillation
  description: Continuous AF for more than 12 months.
- name: Permanent Atrial Fibrillation
  description: AF accepted as permanent rhythm.
- name: Valvular Atrial Fibrillation
  description: AF associated with mitral stenosis or mechanical valves.
pathophysiology:
- name: Atrial Electrical Remodeling
  description: >
    Rapid atrial rates cause shortening of atrial refractory period and
    loss of rate adaptation, promoting AF maintenance. AF begets AF.
  cell_types:
  - preferred_term: Atrial Cardiomyocyte
    term:
      id: CL:0002129
      label: regular atrial cardiac myocyte
  biological_processes:
  - preferred_term: Cardiac Conduction
    term:
      id: GO:0086001
      label: cardiac muscle cell action potential
  evidence:
  - reference: PMID:39146015
    supports: SUPPORT
    snippet: "NOX2 inhibition normalized atrial action potential duration and abrogated
      obesity-mediated ion channel remodeling with reduced AF burden."
    explanation: This demonstrates that electrical remodeling including altered
      action potential duration is a key pathophysiological mechanism in AF.
  - reference: PMID:38255832
    supports: PARTIAL
    snippet: "Atrial fibrillation (AF) is an arrhythmia that affects the left atrium,
      cardiac function, and the patients' survival rate."
    explanation: Confirms AF affects atrial electrical function and is
      influenced by electrophysiological mechanisms.
- name: Atrial Structural Remodeling
  description: >
    Atrial fibrosis and dilation create substrate for AF maintenance.
    Fibrosis disrupts normal conduction and creates reentrant circuits.
  cell_types:
  - preferred_term: Cardiac Fibroblast
    term:
      id: CL:0002548
      label: fibroblast of cardiac tissue
  evidence:
  - reference: PMID:38255832
    supports: PARTIAL
    snippet: "it is influenced by a complex interplay of autoimmune, inflammatory,
      and electrophysiological mechanisms."
    explanation: Inflammatory mechanisms contribute to structural remodeling
      including fibrosis that maintains AF substrate.
- name: Pulmonary Vein Triggers
  description: >
    Ectopic beats originating from pulmonary vein myocardial sleeves
    commonly trigger AF episodes. These foci have distinct electrophysiology.
- name: Atrial Thrombus Formation
  description: >
    Loss of atrial contraction leads to blood stasis, particularly in
    the left atrial appendage, promoting thrombus formation and embolic stroke.
  evidence:
  - reference: PMID:38255832
    supports: NO_EVIDENCE
    snippet: "Atrial fibrillation (AF) is an arrhythmia that affects the left atrium,
      cardiac function, and the patients' survival rate."
    explanation: AF affects cardiac function including atrial contraction, which
      contributes to thromboembolism risk and impacts patient survival.
phenotypes:
- name: Palpitations
  category: Cardiovascular
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Palpitations
    term:
      id: HP:0001962
      label: Palpitations
  evidence:
  - reference: PMID:35873859
    supports: SUPPORT
    snippet: "Palpitations are the cardinal symptom of AF and many AF therapies are
      targeted towards relieving this symptom."
    explanation: Confirms that palpitations are the primary symptom of atrial
      fibrillation.
- name: Irregular Pulse
  category: Cardiovascular
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Arrhythmia
    term:
      id: HP:0011675
      label: Arrhythmia
- name: Fatigue
  category: Systemic
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  evidence:
  - reference: PMID:26318825
    supports: SUPPORT
    snippet: "Experiencing fatigue, dyspnea and intermittent symptoms produced symptom
      representations and emotional and behavioral responses associated with treatment-seeking
      delay."
    explanation: Confirms fatigue is a common symptom in atrial fibrillation
      that affects patient behavior.
- name: Dyspnea
  category: Respiratory
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Dyspnea
    term:
      id: HP:0002094
      label: Dyspnea
  evidence:
  - reference: PMID:35873859
    supports: SUPPORT
    snippet: "up to two-third of patients also complain of dyspnea as a predominant
      self-reported symptom."
    explanation: Confirms dyspnea is a common and predominant symptom in atrial
      fibrillation patients.
- name: Dizziness
  category: Neurological
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Dizziness
    term:
      id: HP:0002321
      label: Vertigo
- name: Stroke
  category: Neurological
  frequency: OCCASIONAL
  notes: Major complication due to thromboembolism
  phenotype_term:
    preferred_term: Stroke
    term:
      id: HP:0001297
      label: Stroke
genetic:
- name: KCNQ1
  association: Risk Factor
- name: KCNE2
  association: Risk Factor
- name: KCNJ2
  association: Risk Factor
- name: SCN5A
  association: Risk Factor
- name: PITX2
  association: Risk Factor
  notes: Major GWAS locus
  evidence:
  - reference: PMID:39146015
    supports: PARTIAL
    snippet: "Unbiased transcriptomics analysis revealed that NOX2 mediates atrial
      remodeling in obesity-mediated AF in DIO mice, PA-treated hiPSC-aCMs, and human
      atrial tissue from obese individuals by upregulation of paired-like homeodomain
      transcription factor 2 (PITX2)."
    explanation: Demonstrates PITX2 plays a mechanistic role in AF
      pathophysiology, supporting its genetic association with AF risk.
  - reference: PMID:35980763
    supports: SUPPORT
    snippet: "In patients with cardiovascular conditions, AF PRS is a strong independent
      predictor of incident AF that provides complementary predictive value when added
      to a validated clinical risk score and NT-proBNP."
    explanation: Polygenic risk score including PITX2 and other loci
      significantly predicts AF risk, validating genetic contributions to AF
      susceptibility.
environmental:
- name: Hypertension
  notes: Most common modifiable risk factor
  evidence:
  - reference: PMID:27057292
    supports: SUPPORT
    snippet: "Of all the risk factors, HTN is the most commonly encountered condition
      in patients with incident AF."
    explanation: Review confirms hypertension is the most common risk factor for
      atrial fibrillation.
- name: Obesity
  notes: Associated with atrial remodeling
  evidence:
  - reference: PMID:39146015
    supports: SUPPORT
    snippet: "Obesity is linked to an increased risk of atrial fibrillation (AF) via
      increased oxidative stress."
    explanation: Establishes obesity as a major risk factor for AF through
      oxidative stress mechanisms.
  - reference: PMID:39146015
    supports: SUPPORT
    snippet: "We showed that NOX2 inhibition normalized atrial action potential duration
      and abrogated obesity-mediated ion channel remodeling with reduced AF burden."
    explanation: Demonstrates that obesity causes atrial remodeling that can be
      reversed by targeting the underlying oxidative stress pathway.
- name: Obstructive Sleep Apnea
  notes: Strong bidirectional relationship
  evidence:
  - reference: PMID:29657903
    supports: SUPPORT
    snippet: "OSA/SDB is strongly associated with AFib confirming the notion that
      OSA/SDB populations are high risk for development of AF."
    explanation: Meta-analysis of 9 studies with 19,837 participants confirms
      OSA as a significant risk factor for AF development.
- name: Alcohol
  notes: Holiday heart syndrome
- name: Hyperthyroidism
  notes: Reversible cause
treatments:
- name: Anticoagulation
  description: Warfarin or DOACs to prevent stroke based on CHA2DS2-VASc score.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    therapeutic_agent:
    - preferred_term: warfarin
      term:
        id: CHEBI:10033
        label: warfarin
    - preferred_term: apixaban
      term:
        id: CHEBI:72296
        label: apixaban
    - preferred_term: rivaroxaban
      term:
        id: CHEBI:68579
        label: rivaroxaban
    - preferred_term: dabigatran
      term:
        id: CHEBI:70752
        label: dabigatran
  evidence:
  - reference: PMID:37573616
    supports: SUPPORT
    snippet: "DOAC was associated with a significantly lower risk of stroke or systemic
      embolism (hazard ratio 0.85, 95% confidence interval 0.75 to 0.96, p = 0.008,
      I2 = 0%), major bleeding, intracranial hemorrhage, and mortality compared with
      warfarin."
    explanation: Meta-analysis of 132,980 patients demonstrates DOACs reduce
      stroke risk in AF patients.
- name: Rate Control
  description: Beta blockers, calcium channel blockers, or digoxin.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    therapeutic_agent:
    - preferred_term: metoprolol
      term:
        id: CHEBI:6904
        label: metoprolol
    - preferred_term: diltiazem
      term:
        id: CHEBI:101278
        label: diltiazem
    - preferred_term: digoxin
      term:
        id: CHEBI:4551
        label: digoxin
- name: Rhythm Control
  description: Antiarrhythmic drugs (amiodarone, flecainide, sotalol).
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    therapeutic_agent:
    - preferred_term: amiodarone
      term:
        id: CHEBI:2663
        label: amiodarone
    - preferred_term: flecainide
      term:
        id: CHEBI:75984
        label: flecainide
    - preferred_term: sotalol
      term:
        id: CHEBI:63622
        label: sotalol
- name: Catheter Ablation
  description: Pulmonary vein isolation for rhythm control.
  treatment_term:
    preferred_term: radiofrequency ablation therapy
    term:
      id: MAXO:0001395
      label: radiofrequency ablation therapy
- name: Cardioversion
  description: Electrical or pharmacological restoration of sinus rhythm.
- name: Left Atrial Appendage Closure
  description: Alternative to anticoagulation in selected patients.
- name: Risk Factor Modification
  description: Weight loss, blood pressure control, sleep apnea treatment.
datasets:
references:
- reference: DOI:10.1038/s41467-024-54296-w
  title: Large-scale single-nuclei profiling identifies role for ATRNL1 in
    atrial fibrillation
  findings: []
- reference: DOI:10.1038/s41569-022-00759-w
  title: 'Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle
    in atrial fibrillation pathophysiology'
  findings: []
- reference: DOI:10.1038/s42003-024-07308-w
  title: Left atrial single-cell transcriptomics reveals amphiregulin as a
    surrogate marker for atrial fibrillation
  findings: []
- reference: DOI:10.1093/cvr/cvad175
  title: An inflammation resolution–promoting intervention prevents atrial
    fibrillation caused by left ventricular dysfunction
  findings: []
- reference: DOI:10.1093/eurheartj/ehac460
  title: A polygenic risk score predicts atrial fibrillation in cardiovascular
    disease
  findings: []
- reference: DOI:10.1172/jci175447
  title: Modulation of NOX2 causes obesity-mediated atrial fibrillation
  findings: []
- reference: DOI:10.21037/jtd-23-1981
  title: 'Development of neuromodulation for atrial fibrillation: a narrative review'
  findings: []
- reference: DOI:10.3389/fcvm.2023.1327387
  title: The autonomic nervous system in atrial fibrillation—pathophysiology and
    non-invasive assessment
  findings: []
- reference: DOI:10.3390/ijms25010535
  title: 'Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial
    Dysfunction and Oxidative Stress: A Scoping Review'
  findings: []
- reference: DOI:10.3390/ijms25020758
  title: Pathophysiology of Atrial Fibrillation and Approach to Therapy in
    Subjects Less than 60 Years Old
  findings: []
- reference: DOI:10.3390/ijms26135954
  title: 'Inflammasome Signaling in Cardiac Arrhythmias: Linking Inflammation, Fibrosis,
    and Electrical Remodeling'
  findings: []
- reference: DOI:10.3390/jcm14030882
  title: Exploring Anti-Inflammatory Treatment as Upstream Therapy in the
    Management of Atrial Fibrillation
  findings: []
- reference: DOI:10.3390/jcm14093250
  title: 'Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging
    Treatment Concepts'
  findings: []
- reference: DOI:10.7150/thno.89520
  title: Inactivation of the NLRP3 inflammasome mediates exosome-based
    prevention of atrial fibrillation
  findings: []
